Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Chief Transformation Officer | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 20,232 |
Ending reported balance
After 2026-09-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-15 · Grant · Acquired 2,592 · Balance 21,443 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Row 2 · 2026-09-15 · Tax withholding · Disposed 320 · Balance 21,123 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 3 · 2026-09-15 · Tax withholding · Disposed 309 · Balance 20,814 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 4 · 2026-09-15 · Tax withholding · Disposed 274 · Balance 20,540 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 5 · 2026-09-16 · Tax withholding · Disposed 308 · Balance 20,232 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 282 | $182.01 | $51,326.82 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 2 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,043 F2 · shares: Mr. Vroman surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2020 Filed Mar 17, 2020 20:41 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000029 · edgardoc.xml · nonDerivative · entry 1 Vroman Ken · CIK 0001429863 · Sr MD International & Optimiza 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,325 F1 · shares: Represents shares earned from a 2016 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2017-2019. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.